MedPath

Study of the effect of Nandrolone ampoule in facilitating the separation of mechanical ventilatio

Phase 3
Recruiting
Conditions
All patients have long-term ventilation with the same Apache screw.
Registration Number
IRCT20180804040695N1
Lead Sponsor
Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Patient with long-term separation of mechanical ventilation (over SBT 3 or 7 days from the first SBT to 3 weeks)
separate inspiration weakness (caused by myopathy or neuropathy caused by respiratory muscles for any reason).
Age 20 to 70 years
Sepsis or febrile illness that causes a kind of neuropathy.
Lack of lung disease (such as nano-pulmonary pleural effusion-respiratory failure-pulmonary mass and COPD)
Patients with the same nutrition or gavage
Length of stay in ICU less than 21 days.
No electrolyte imbalance
NIF having> 30

Exclusion Criteria

Reintubation
Patient death before ICU clearance
NPO becoming patient during examination
Incidence of pulmonary edema, ARDS, pleural effusion and ventilator pneumonia
Electrolyte disturbances (hypokalemia, etc.) at any time during the study.
Dissatisfaction with the patient's companions
Contraindication for the injection of nandrolone such as CHF, recent history of IHD or MI, obstructive europoplasty (BPH) in men, hematocrit over 50 (erythrocytosis), and chronic kidney and liver disease (Increase LFT)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Facilitate separation of ventilators in patients with long-term mechanical ventilation. Timepoint: In 3 stages, 3, 5 and 7 per week, variables such as static capacity, R.S.R.I, I.W.I, CORP Index. Method of measurement: Questionnaire (Static Compliace, R.S.R.I, I.W.I, CORP Index).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath